Rite Aid to carry Acura's anti-meth conversion drug
Palatine-based Acura Pharmaceuticals announced that Nexafed pseudoephedrine hydrochloride, its next generation pseudoephedrine with abuse deterrent technology, will now be stocked by Rite Aid pharmacies.
Nexafed is a 30 mg immediate-release pseudoephedrine product that combines effective nasal-congestion relief with a unique technology that disrupts the conversion of pseudoephedrine into the drug methamphetamine. Meth production and abuse is a growing problem in communities nationwide.
The next generation Nexafed tablet combines effective nasal-congestion relief with Impede technology, a unique polymer matrix that disrupts the conversion of pseudoephedrine into methamphetamine. Specifically, the Impede technology forms a thick gel when the tablets are dissolved in solvents typically used in the pseudoephedrine extraction or methamphetamine production processes, trapping the pseudoephedrine or converted methamphetamine to prevent its isolation or purification.
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address medication abuse and misuse.
- Share Facebook Twitter
Article sent to (required)E-mail
Article sent from (required)E-mail Name
Subject Line (article title)
Message (optional)Success - Article sent Click to close
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.Need more information about reprints? Visit our Reprints Section for more details.
Contact information ( * required )Name * Company Telephone * E-mail *
Article InformationTitle URL
Message (optional)Success - Reprint request sent Click to close